home / stock / eryp / eryp news

ERYP News and Press, Erytech Pharma S.A. From 03/19/20

Stock Information
Company Name: Erytech Pharma S.A.
Stock Symbol: ERYP
Market: NASDAQ
Menu
ERYP ERYP Quote ERYP Short ERYP News ERYP Articles ERYP Message Board
Get ERYP Alerts

News, Short Squeeze, Breakout and More Instantly...
ERYP - ERYTECH Announces Filing of 2019 Universal Registration Document and 2019 Annual Report on Form 20-F

LYON, France and CAMBRIDGE, Mass., March 19, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announced that it had fi...
ERYP - ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q4 2019 Results - Earnings Call Transcript

ERYTECH Pharma S.A. (ERYP) Q4 2019 Earnings Conference Call March 17, 2020 8:30 AM ET Company Participants Gil Beyen - Chief Executive Officer Eric Soyer - Chief Financial Officer and Chief Operating Officer Iman El-Hariry - Chief Medical Officer Conference Call Participants...

ERYP - ERYTECH Pharma S.A. 2019 Q4 - Results - Earnings Call Presentation

The following slide deck was published by ERYTECH Pharma S.A. in conjunction with their 2019 Q4 earnings Read more ...

ERYP - ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2019

More than two-thirds of the expected number of patients have been enrolled in the TRYbeCA‑1 Phase 3 clinical trial Cash position of €73.2 million ($82.2 million) at the end of 2019 LYON, France and CAMBRIDGE, Mass., March 16, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma ...
ERYP - ERYTECH Announces the Appointment of Dr. Melanie Rolli to its Board of Directors

LYON, France and CAMBRIDGE, Mass. , March 16, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced the appoin...

ERYP - ERYTECH to Host Fourth Quarter and Full Year 2019 Conference Call and Business Update

LYON, France, March 12, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host its fou...

ERYP - Monthly information related to total number of voting rights and shares composing the share capital - February 29, 2020

Article 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France, March 06, 2020 (GLOBE NEWSWIRE) -- Listing markets: Euronext Paris from Euronext (Market segment C -  ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Mar...
ERYP - ERYTECH to Present at Cowen and Company 40th Annual Health Care Conference

LYON, France and CAMBRIDGE, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that Gil Bey...

ERYP - ERYTECH Enters Into Strategic Supply Partnership with the German Red Cross Blood Donor Service

Second European source of donor red blood cells secured in preparation for expanded production of red blood cell-based therapeutics LYON, France and CAMBRIDGE, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical ...

ERYP - Monthly information related to total number of voting rights and shares composing the share capital - January 31, 2020

LYON, France, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Listing markets: Euronext Paris from Euronext (Market segment C -  ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP) Website : www.erytech.com     ...
Previous 10 Next 10